ArticleJournal of translational medicine2024

CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles.

Marc Terrones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.